Finding evidence that supports an intervention does not automatically justify changing practice. The decision depends on the certainty and consistency of the evidence, the importance of the observed effect, how well the evidence applies to the population and setting, and what the change would require in practice.
For DNP students, this is where evidence appraisal becomes evidence translation. The question shifts from whether a study is credible to whether the available evidence provides enough confidence to act.
Look at the Body of Evidence, Not the Most Convincing Study
A single well-designed study can provide important information, but practice decisions are usually stronger when supported by a body of evidence. When studies disagree, differences in populations, interventions, outcomes, follow-up, or methodological limitations may help explain why.
The GRADE approach evaluates certainty in a body of evidence for a particular outcome using five domains: risk of bias, inconsistency, indirectness, imprecision, and publication bias. Certainty is categorized as high, moderate, low, or very low (Schünemann et al., 2024). A randomized trial can have important limitations, while nonrandomized evidence may still contribute useful information depending on the question and the quality of the evidence.
Decide Whether the Effect Is Large Enough to Matter
Evidence can support the existence of an effect without establishing that the effect is important enough to justify changing practice. A statistically significant difference may represent a clinically meaningful improvement, a very small benefit, or an effect too uncertain to interpret confidently. Effect estimates and confidence intervals provide more useful information than the p value alone because they help show the magnitude and precision of the result.
Baseline risk also affects interpretation. The same relative effect can produce substantially different absolute benefits in populations with different underlying risks. An intervention that prevents an important outcome in a high-risk population may offer considerably less absolute benefit when applied to a lower-risk group.
GRADE incorporates imprecision into judgments about certainty. Wide confidence intervals can leave open meaningfully different conclusions about the effect, including both little or no benefit and an effect large enough to influence the decision. The magnitude and precision of the estimated benefit therefore have to be considered alongside the certainty of the evidence and the other factors relevant to the decision (Schünemann et al., 2024).
Make Sure the Evidence Answers Your Actual Practice Question
Strong evidence can still be indirect when the population differs from the patients receiving care locally, the intervention requires resources unavailable in the proposed setting, the comparator no longer reflects current practice, or investigators measured a surrogate outcome when the decision depends on a patient-important result.
GRADE treats differences involving the population, intervention, comparator, and outcomes as potential sources of indirectness when they limit how directly the evidence answers the question being considered (Schünemann et al., 2024). Applicability does not require finding a study that perfectly reproduces the local environment. It requires identifying differences that could plausibly change the expected benefit, harm, or ability to deliver the intervention.
Consider Benefits and Harms Together
Evidence supporting a benefit is only part of a practice decision. An intervention may also produce harms, treatment burden, additional workload, costs, or unintended consequences. GRADE Evidence-to-Decision frameworks extend the assessment beyond certainty of evidence by considering desirable and undesirable effects, values, resource use, equity, acceptability, and feasibility when developing recommendations (Alonso-Coello et al., 2016). A favorable average effect may also be less compelling when patients place very different values on the expected benefit, burden, or potential harms.
The balance may be straightforward when an intervention offers substantial benefit with little risk or burden. Decisions become harder when the expected benefit is modest, harms remain uncertain, or implementation requires substantial resources. The consequences can also fall unevenly across a system. A screening process may identify more patients who need services without increasing the capacity of the program receiving those referrals. Evaluating the evidence therefore includes considering both the intended benefit and the burdens required to produce it.
Determine Whether the Change Can Work in the Local System
Evidence establishes what happened under the conditions in which it was studied. Implementation occurs under local conditions. Local workflow, staffing, resources, patient needs, and organizational capacity can determine whether an evidence-supported intervention can be delivered as intended.
AHRQ recommends selecting evidence based partly on its importance and impact for patients and its alignment with practice priorities, then customizing that evidence to the practice environment and workflow (Agency for Healthcare Research and Quality [AHRQ], 2018). Local workflow, resources, patient needs, and implementation barriers may identify where adaptation is necessary before broader implementation. AHRQ’s EvidenceNOW model also places data-driven quality improvement alongside evidence selection as part of integrating evidence into practice.
Adaptation still requires judgment. If an intervention is changed substantially, the connection between the published evidence and what is ultimately implemented may become less certain. A locally feasible version of an intervention may no longer be equivalent to the intervention that produced the published outcomes.
Test the Change Before Assuming It Will Work Everywhere
A decision to act on evidence does not require certainty that the intervention will perform identically in the local setting. The Institute for Healthcare Improvement recommends testing changes on a small scale, learning from successive tests, and expanding them under different conditions before permanent implementation. This process can reveal workflow problems, unexpected effects, costs, and modifications needed for the local environment (Institute for Healthcare Improvement [IHI], n.d.).
Small-scale testing creates a useful space between rejecting an intervention because local outcomes are unknown and making a change permanent across an organization before learning how it performs locally. Evidence can justify trying a change before it justifies making that change permanent.
Know When Uncertainty Is Still Too High
Lower certainty does not automatically mean an intervention should not be used, and certainty alone does not determine the strength of a recommendation. GRADE Evidence-to-Decision frameworks also consider the balance of desirable and undesirable effects, values, resource use, equity, acceptability, feasibility, and other contextual factors relevant to the decision (Alonso-Coello et al., 2016).
The amount of uncertainty that can reasonably be accepted also depends on what is being proposed. Evidence sufficient to justify a limited, reversible practice test may not justify replacing an established practice across an entire health system.
Evidence Has to Support the Decision You Are Actually Making
AACN’s 2026 Essentials expect advanced-level nurses to evaluate the strength of evidence, lead its translation into practice, and evaluate the outcomes of new practices (American Association of Colleges of Nursing [AACN], 2026). Before changing practice, the evidence should support the expected benefit with enough certainty to justify acting, apply reasonably well to the population and setting, and remain favorable after harms and practical consequences are considered.
The local system then has to determine whether the change can be delivered as intended and whether it produces the improvement expected from it. The strongest evidence does not eliminate uncertainty. It reduces uncertainty enough to make a defensible decision about what should happen next.
References
Agency for Healthcare Research and Quality. (2018). Key Driver 1: Seek, select, and customize the best evidence for use by the practice. https://www.ahrq.gov/evidencenow/tools/keydrivers/seek-evidence.html
Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., Guyatt, G. H., Schünemann, H. J., & GRADE Working Group. (2016). GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ, 353, i2089. https://doi.org/10.1136/bmj.i2089
American Association of Colleges of Nursing. (2026). The Essentials: Core competencies for professional nursing education. https://www.aacnnursing.org/Portals/0/PDFs/Publications/Essentials-2026.pdf
Institute for Healthcare Improvement. (n.d.). Model for Improvement: Testing changes. Retrieved August 16, 2026, from https://www.ihi.org/library/model-for-improvement/testing-changes
Schünemann, H. J., Higgins, J. P. T., Vist, G. E., Glasziou, P., Akl, E. A., Skoetz, N., & Guyatt, G. H. (2024). Completing “Summary of findings” tables and grading the certainty of the evidence. In J. P. T. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. J. Page, & V. A. Welch (Eds.), Cochrane handbook for systematic reviews of interventions (Version 6.5). Cochrane. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-14